Life sciences investor Vie Ventures has been launched by former MPM Capital pair Steven St Peter and Luke Evnin, with eyes on bridging VC and disease philanthropy to develop breakthrough therapies for patients.
The post New life sciences investor Vie Ventures eyes up to $200m for debut fund appeared first on AltAssets Private Equity News.